# 

> Discover how real-time aging measures packaging performance over time, ensuring safety and compliance under ISO 11607.

Source: https://lso-inc.com/medical-package-testing/services/real-time-aging/

---

# Real-Time Aging and ISO 11607 Requirements Explained

[Get a Validation Plan Reviewed](https://lso-inc.com/solutions/packaging-validation/#intake-form)

![Real-Time Aging and ISO 11607 Requirements Explained](https://lso-inc.com/api/media/file/Real-timeagingandISOcomplianceinfographic.webp)

FDA-Registered

Manufacturing Facility

ISO 13485

Certified Quality System

12 Cleanrooms

Class 5–8

125,000+ Sq Ft

Regulated Manufacturing

3 Facilities

CA | NH | Costa Rica

ISO 17025

Accredited Packaging Lab

Real-time aging provides the **actual shelf-life evidence** required for sterile barrier validation. Unlike [accelerated aging](https://lso-inc.com/medical-package-testing/services/accelerated-aging/)—which estimates long-term performance using elevated temperatures—real-time aging measures how a packaging system performs **over the true passage of time** under controlled room temperature conditions. 

Real-time aging is **mandatory under** [**ISO 11607**](https://lso-inc.com/medical-package-testing/standards/iso-11607/) for verifying the shelf-life claims of terminally sterilized medical devices. It confirms that sterile barrier systems maintain integrity, material stability, and seal performance throughout the entire claimed shelf life. 

**Q: Why is real-time aging mandatory under ISO 11607?**   
A: [ISO 11607](https://www.iso.org/standard/70799.html) requires manufacturers to generate real-time data demonstrating that sterile barrier systems maintain integrity over the complete shelf-life duration. 

## What Real-Time Aging Is and Why It Matters

Real-time aging evaluates how packaging materials, seals, and sterile barriers perform **at normal storage temperatures** over months or years. It provides: 

-   True, empirical shelf-life data 
-   Verification of accelerated aging assumptions 
-   Evidence required for regulatory submissions 
-   Long-term sterile barrier performance validation  
    

  
Real-time aging is the foundation for demonstrating stability and durability of sterile packaging over its intended lifespan. 

**Q: Does real-time aging provide the actual shelf-life data regulators want?**   
A: Yes. Real-time aging is the only method that produces direct, time-based shelf-life evidence for sterile barrier systems. 

## Environmental Conditions Used for Real-Time Aging (22–25°C)

Real-time aging must reflect real-world storage conditions. ISO 11607 requires manufacturers to maintain stable, controlled environments throughout the study. 

Typical conditions: 

-   **Temperature:** 20°C–25°C 
-   **Most common range:** **22°C–25°C** 
-   **Humidity:** Ambient unless otherwise justified 
-   **Lighting:** Controlled, non-degrading exposure 
-   **Monitoring:** Continuous environmental logging with excursion alarms 

  
LSO’s real-time aging rooms are fully mapped, monitored, and designed to ensure reproducible stability conditions throughout multi-year studies. 

**Q: What temperature is used for real-time aging?**   
A: Real-time aging is typically performed at 22–25°C, reflecting standard ambient storage conditions. 

## LSO’s Real-Time Aging Capabilities (California Facility)

LSO conducts real-time aging exclusively in our **California facility**, equipped for long-term stability studies requiring strict environmental control and traceability. 

**Facility Highlights** 

-   Temperature-controlled rooms maintained between **22°C–25°C** 
-   Full **temperature mapping** prior to study initiation 
-   Continuous environmental monitoring with excursion alarms 
-   Segregated shelving for study groups and time points 
-   Co-located sterile barrier integrity testing (no cross-facility transport) 
-   Long-term capacity for multi-year studies and multiple SKUs 

**Q: Why does LSO conduct real-time aging in California only?**   
A: Our California facility houses mapped, monitored rooms purpose-built for long-duration stability studies and co-located package integrity testing. 

## Real-Time Aging vs Accelerated Aging: What’s the Difference?

Real-time aging and accelerated aging serve different—yet complementary—roles in shelf-life validation. 

| Category | Real-Time Aging | Accelerated Aging (ASTM F1980) |
| --- | --- | --- |
| Purpose | Establishes actual shelf-life data | Estimates shelf-life before real-time results exist |
| Temperature | 20–25°C (typically 22–25°C) | 50–60°C depending on material limits |
| Basis | Measured passage of time | Arrhenius equation (aging factor) |
| Regulatory Role | Mandatory under ISO 11607 | Supports initial shelf-life claims only |
| Testing | Integrity tests at every time point | Integrity testing after AA duration |
| Timeframe | Months to years | Weeks to months |
| When Used | All sterile barrier claims | Early validation + pre-launch justification |
| Relationship | Confirms AA assumptions | Provides early data before real-time completes |

**Q: Can accelerated aging replace real-time aging for shelf-life validation?**   
A: No. [Accelerated aging](https://lso-inc.com/medical-package-testing/services/accelerated-aging/) is useful early in development, but real-time aging is mandatory for confirming shelf-life claims. 

## How Real-Time Aging Studies Are Planned and Executed

Because real-time aging cannot be compressed, study planning should begin early in the development cycle. 

A typical study includes: 

1.  Defining study duration (1, 2, 3+ years) 
2.  Selecting required time points (6, 12, 18, 24 months) 
3.  Allocating sterilized samples for each interval 
4.  Placing samples in controlled 22–25°C rooms 
5.  Pulling samples at each time point 
6.  Performing package integrity testing 
7.  Recording and reviewing results 
8.  Issuing a final real-time aging report 

**Q: How early should real-time aging be started?**   
A: As early as possible, because real-time duration cannot be shortened and is required for all final shelf-life claims. 

## Real-Time Aging Workflow at LSO

LSO manages the full workflow to ensure data integrity and regulatory acceptance. 

**Our Process** 

1.  Study setup, chamber qualification, and sample intake 
2.  Continuous temperature monitoring with alerting 
3.  Scheduled time-point pulls 
4.  In-house sterile barrier integrity testing: 
5.  -   [Seal strength](https://lso-inc.com/medical-package-testing/services/peel-strength-testing/) 
    -   [Bubble leak](https://lso-inc.com/medical-package-testing/services/bubble-emission-testing/) 
    -   [Dye penetration](https://lso-inc.com/medical-package-testing/services/dye-penetration-testing/) 
    -   [Visual inspection](https://lso-inc.com/medical-package-testing/services/visual-inspection/) 
6.  Data verification and documentation 
7.  Final reporting aligned with [ISO 11607](https://lso-inc.com/medical-package-testing/standards/iso-11607/) requirements 

**Q: What happens at each time point?**   
A: Samples are removed from aging rooms and undergo required package integrity testing to verify sterile barrier performance over time. 

### Why Medical Device Manufacturers Choose LSO

LSO provides: 

-   ISO 13485-certified facilities 
-   Validated aging and environmental chambers with continuous monitoring 
-   Integrated [accelerated aging](https://lso-inc.com/medical-package-testing/services/accelerated-aging/) + sterile barrier testing 
-   Accelerated turnaround 
-   Regulatory expertise for 510(k), PMA, and global submissions 
-   Complete documentation packages for audits and submissions

You reduce handoffs, shorten timelines, and receive shelf-life data with full regulatory alignment. 

## Talk to a Medical Package Testing Specialist

If you’re planning a new shelf-life claim, updating your packaging system, or aligning your validation program with [ISO 11607](https://lso-inc.com/medical-package-testing/standards/iso-11607/), LSO’s specialists can help design and execute real-time and accelerated aging studies with full in-house testing support. 

[Talk to a Packaging Specialist](https://lso-inc.com/contact/)

## Frequently Asked Questions About Real-Time Aging

What is real-time aging?

Real-time aging involves storing sterile packaging at controlled ambient temperatures (22–25°C) for the full claimed shelf life to generate actual aging data.

Why is real-time aging mandatory?

ISO 11607 requires real-time evidence to substantiate sterile barrier shelf-life claims.

How long does real-time aging take?

Exactly as long as the shelf-life claim. Real-time aging cannot be compressed.

How often is testing performed?

Testing occurs at each defined time point, commonly every 6–12 months.

Where does LSO conduct real-time aging?

In our mapped, monitored California facility.

Can accelerated aging replace real-time?

No. Accelerated aging provides early estimates; real-time aging provides mandatory confirmation.

## Ready to get started?

[Get a Validation Plan Reviewed](https://lso-inc.com/solutions/packaging-validation/#intake-form) [Explore Solutions](https://lso-inc.com/#solutions)
